NCT00046293View on ClinicalTrials.gov

ReoPro and Retavase to Treat Acute Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 24, 2002

Primary Completion Date

July 20, 2007

Study Completion Date

July 20, 2007

Conditions
Cerebrovascular Accident
Interventions
DRUG

Reopro

DRUG

Retrovase

Trial Locations (3)

20010

Washington Hospital Center, Washington D.C.

20814

Suburban Hospital, Bethesda

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00046293 - ReoPro and Retavase to Treat Acute Stroke | Biotech Hunter | Biotech Hunter